Gamida Cell announces $75 million financing with Highbridge Capital Management
16.02.21 | CTech
This site uses cookies to ensure the best viewing experience for our readers.
Gamida Cell
5 stories about Gamida Cell
Gamida Cell Downprices Shares to Raise $50 Million Nasdaq IPO
28.10.18 | Lilach Baumer
Novartis-Backed Gamida Downgrades Nasdaq IPO Expectations to $50-$60 Million
18.10.18 | Lilach Baumer
Biotech Company Gamida Cell Files for $69 Million Nasdaq IPO
30.09.18 | Dror Reich
Pharma Veteran Julian Adams takes Helm at Gamida Cell
21.11.17 | Lilach Baumer
Tag does not exist. Please try again.